Coronary CTA for Assessing CAD - Are We There Yet?

Matthew Budoff

The GOOD and the BAD Side of GLP-1s and What to Do If You Get Caught…

Endocrinology 2024 Year in Review

Weightloss in Menopause

Susan Brian

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

University of Colorado Department of Medicine

R. Johnson

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

Robert Busch

Hypertension 2025: New Guidelines and Resistant Hypertension

University of Louisville

K. Ferdinand

Cholesterol Treatment Decisions: Recent Updates to Guidelines and St…

Gary Martin

Tirzepatide Updates

Diana Isaacs

The Deadly Paradox: Current Practice, Driven by Guidelines, Is Not A…

Michael Makover

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Keck School of Medicine of USC

M. Goran

The Differences Between the Products of GLP1's and GLP/GIPs

Susan Brian

Vitamin D Deficiency

Keck School of Medicine of USC

V. Gevorgyan

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Practical Ways to Achieve Targets in Diabetes Care

S. Nissen

Obesity Pharmacotherapy: Breaking the Chain of Cardio-Renal-Metaboli…

Cleveland Clinic - Digestive Disease Institute

S. Pannain

Biomarkers in Gaucher Disease: An Evolution

The France Foundation

P. Kishnani

ACC 2024 Insights: A Plant-Based Diet

ACC 2024 Insights

N. Barnard

Chest Pain in Emergency Department Settings

University Hospitals

G. Rao, R. Hughes

Major Advancements in MASH Management

Rush University Medical Center

S. Janardhan

Type 2 Diabetes Aetiology and Reversibility

Jason Fung

Anti-Obesity Medications

Michigan Medicine

D. H. Griauzde